Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 4 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 75Genitourinary 13Gynecologic 11Sarcoma 10Head & Neck 8CNS 4Other hematologic neoplasm 3Gastrointestinal 3Dermatologic 3Breast 2Tumor-Agnostic 1Thoracic 1Plasma cell 1

Conditions

Skin Neoplasms 2Melanoma 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 326Nivolumab 289Ipilimumab 260Cyclophosphamide 193aldesleukin 145Interleukin-2 109fludarabine phosphate 106Temozolomide 83Dacarbazine 81fludarabine 80Radiotherapy 74trametinib 73Vemurafenib 69dabrafenib 66Biopsy 65sargramostim 50Bevacizumab 50Radiosurgery 49Paclitaxel 49Peripheral Blood Stem Cell Transplantation 48Carboplatin 48Magnetic Resonance Spectroscopy 47Imiquimod 47Aminolevulinic Acid 47binimetinib 45Cisplatin 45CTLA-4 Antigen 43cemiplimab 42atezolizumab 41Specimen Handling 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Bleomycin × Dermatologic × Clear all
NCT06647342 2025-01-23

BLESS

Zealand University Hospital

Phase 4 Recruiting
55 enrolled
Dermatologic

Skin Neoplasms

NCT00993512 2019-04-29

Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer

PCI Biotech AS

Phase 1 Completed
19 enrolled
DermatologicHead & Neck

Head and Neck Neoplasms, Skin Neoplasms

NCT00006035 2013-09-17

Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma

National Cancer Institute (NCI)

Phase 1 Unknown
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡